Ftse Mib
33.746,66
-1,60%
DAX
17.932,17
-1,10%
S&P 500
5.035,69
-1,57%
NASDAQ Composite
15.657,82
-2,04%
Bitcoin
59.642,70
-1,58%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ OpGen Inc (OPGN) OpGen Inc (OPGN) Notizie

OpGen Inc

OPGN
0,449
-0,086 (-16,07%)
01 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
29/4/202422:05GLOBEOpGen Provides Update on Business Operations and Strategic..
23/4/202422:15GLOBEOpGen Receives Nasdaq Notice Regarding Delayed Form 10-K
26/3/202421:20APSShares Rip In Reaction To Activist Investor Becoming CEO
25/3/202421:05GLOBEOpGen Announces Acquisition of Preferred Stock by David..
13/2/202422:30EDGAR2Form 8-K - Current report
08/2/202413:30EDGAR2Form 8-K - Current report
09/1/202422:30EDGAR2Form 8-K - Current report
12/12/202322:58EDGAR2Form 8-K - Current report
05/12/202322:37EDGAR2Form 8-K - Current report
24/11/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
14/11/202322:30GLOBEOpGen Reports Third Quarter 2023 Financial Results and..
13/11/202322:59EDGAR2Form S-3 - Registration statement under Securities Act of..
07/11/202322:30EDGAR2Form 8-K - Current report
26/10/202322:30EDGAR2Form 8-K - Current report
16/10/202322:30EDGAR2Form 8-K - Current report
13/10/202323:18EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
13/10/202323:17EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/10/202323:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
13/10/202323:14EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
13/10/202323:13EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/10/202318:32GLOBEOpGen Enters Into Warrant Inducement Transaction for up to..
11/10/202322:40EDGAR2Form 8-K - Current report
11/10/202322:30EDGAR2Form 8-K - Current report
28/9/202322:24EDGAR2Form RW - Registration Withdrawal Request
08/9/202322:30EDGAR2Form 8-K - Current report
07/9/202322:30EDGAR2Form 8-K - Current report
14/8/202314:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202322:31EDGAR2Form 8-K - Current report
10/8/202322:15GLOBEOpGen Reports Second Quarter 2023 Financial Results and..
07/8/202313:30GLOBEOpGen’s Subsidiary Ares Genetics Releases New Features to..
03/8/202314:00GLOBEOpGen’s Subsidiary Curetis and FIND Extend R&D Collaboration..
03/8/202313:30GLOBEOpGen to Provide Business Update and Financial Results for..
01/8/202315:40EDGAR2Form DEF 14A - Other definitive proxy statements
21/7/202322:55EDGAR2Form PRE 14A - Other preliminary proxy statements
19/7/202313:30GLOBEOpGen’s Subsidiary Curetis Meets Milestones of Extended and..
14/7/202322:30EDGAR2Form S-1 - General form for registration of securities under..
05/7/202322:30EDGAR2Form 8-K - Current report
30/6/202322:30EDGAR2Form 8-K - Current report
26/6/202313:30GLOBEOpGen Subsidiary Ares Genetics Successfully Maintains Key..
22/6/202313:30GLOBEOpGen’s Subsidiary Curetis Receives Batch of Ten New..
20/6/202313:30GLOBEOpGen Presents Unyvero Urinary Tract Infection Panel Trial..
15/5/202322:15GLOBEOpGen Reports First Quarter 2023 Financial Results and..
08/5/202313:30GLOBEOpGen to Provide Business Update and Financial Results for..
04/5/202322:30GLOBEOpGen Announces Closing of $3.5 Million Public Offering
02/5/202303:00GLOBEOpGen Announces Pricing of $3.5 Million Public Offering
Apertura: 0,50 Min: 0,4026 Max: 0,50
Chiusura: 0,535

La tua Cronologia

NASDAQ
OPGN
OpGen
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network